Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy.
about
Amyotrophic lateral sclerosis: a focus on disease progressionLack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule.Tetanus Toxin Hc Fragment Induces the Formation of Ceramide Platforms and Protects Neuronal Cells against Oxidative Stress.Tetanus toxin C-fragment: the courier and the cure?Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical applicationType I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression.Sigma-1R agonist improves motor function and motoneuron survival in ALS mice.Fragment C of tetanus toxin: new insights into its neuronal signaling pathway.ALS Untangled No. 21: Fecal transplants.Neuroprotective Effect of Non-viral Gene Therapy Treatment Based on Tetanus Toxin C-fragment in a Severe Mouse Model of Spinal Muscular AtrophyFragment C Domain of Tetanus Toxin Mitigates Methamphetamine Neurotoxicity and Its Motor Consequences in Mice.The C-terminal domain of tetanus toxin protects motoneurons against acute excitotoxic damage on spinal cord organotypic cultures.DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.Traumatic Brain Injury Results in Cellular, Structural and Functional Changes Resembling Motor Neuron Disease.Tetanus toxin fragments and Bcl-2 fusion proteins: cytoprotection and retrograde axonal migration.Effect of genetic background on onset and disease progression in the SOD1-G93A model of amyotrophic lateral sclerosisTetanus toxin C-fragment protects against excitotoxic spinal motoneuron degeneration in vivo
P2860
Q34064143-6D307B15-2438-4C42-A176-830243B72C53Q34769867-C1D11D03-23CC-409F-BB11-3A509C559CC9Q34797732-967980CE-03E4-4195-9641-F6FC77704FE3Q35155645-47FE9E99-44E4-4133-B142-BAFE76CFEDA8Q36117618-EAB4FF44-C1FC-469B-97EB-E2125F6E72CDQ36332951-49292121-6EC7-44DC-9973-0DB9E332BB08Q36345436-31E680F8-E376-4143-A85A-955D5969685AQ38030004-6FFC700B-FD90-4BF4-87D5-94934642C54AQ38122757-72228ECD-82BF-4B20-8076-B9B60FD21A79Q40590397-7980D6DF-FD20-4043-BC79-3BF98498F2F8Q40983371-E541134C-F900-46EC-8B8F-BD8A485CE0AFQ43578360-A52C4F31-ED74-4469-BAA3-4E7366EA1A92Q47907429-B96334F8-29B0-41CF-BF31-CA02B96A1769Q47951993-79353B74-59AA-4684-B02D-5E3E7ABCE277Q55402096-B5671EA0-B7F5-4B76-859D-3E37053E7497Q58264939-22E70D1C-CD73-467E-AAB6-478202CDC5CAQ58589569-A3E534EA-CABB-4887-B259-22008F7B047A
P2860
Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Fragment C of tetanus toxin, m ...... in non-viral ALS gene therapy.
@en
Fragment C of tetanus toxin, m ...... in non-viral ALS gene therapy.
@nl
type
label
Fragment C of tetanus toxin, m ...... in non-viral ALS gene therapy.
@en
Fragment C of tetanus toxin, m ...... in non-viral ALS gene therapy.
@nl
prefLabel
Fragment C of tetanus toxin, m ...... in non-viral ALS gene therapy.
@en
Fragment C of tetanus toxin, m ...... in non-viral ALS gene therapy.
@nl
P2093
P50
P1476
Fragment C of tetanus toxin, m ...... in non-viral ALS gene therapy.
@en
P2093
María Jesús Muñoz
María Moreno-Igoa
Pilar Zaragoza
Raquel Manzano
Rosario Osta Pinzolas
Sara Oliván
P2888
P304
P356
10.1007/S00109-009-0556-Y
P577
2010-03-01T00:00:00Z